Cogent Biosciences
(NASDAQ) COGT
Cogent Biosciences Financials at a Glance
Market Cap
$6.41B
Revenue (TTM)
$0.00
Net Income (TTM)
-$354.30M
EPS (TTM)
-$2.52
P/E Ratio
-14.87
Dividend
$0.00
Beta (Volatility)
1.18 (Average)
Dividend
$0.00
Beta (Volatility)
1.18 (Average)
Price
$39.41
Volume
739,955.092
Open
$37.53
Price
$39.41
Volume
739,955.092
Open
$37.53
Previous Close
$37.53
Daily Range
$37.45 - $39.50
52-Week Range
$7.03 - $43.73
Estimated Earnings Date
Aug 4, 2026
Dividend
$0.00
Beta (Volatility)
1.18 (Average)
Price
$39.41
Volume
739,955.092
Open
$37.53
Previous Close
$37.53
Daily Range
$37.45 - $39.50
52-Week Range
$7.03 - $43.73
Estimated Earnings Date
Aug 4, 2026
COGT News
COGT: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Cogent Biosciences
Industry
Biotechnology
Sector
Health CareEmployees
258
CEO
Andrew R. Robbins, MBA
Website
www.cogentbio.comHeadquarters
Waltham, MA 02140, US
COGT Financials
Key Financial Metrics (TTM)
Gross Margin
0.00%
Operating Margin
0.00%
Net Income Margin
0.00%
Return on Equity
-83.29%
Return on Capital
-37.48%
Return on Assets
-39.24%
Earnings Yield
-6.72%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$6.41B
Shares Outstanding
170.91M
Volume
739.96K
Avg. Volume
2.23M
Financials (TTM)
Gross Profit
-$3.49M
Operating Income
-$362.04M
EBITDA
-$350.48M
Operating Cash Flow
-$284.82M
Capital Expenditure
-$1.46M
Free Cash Flow
-$286.27M
Cash & ST Invst.
$866.38M
Total Debt
$238.65M
Cogent Biosciences Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
-$1.16M
N/A
Gross Margin
0.00%
N/A
Market Cap
$6.41B
N/A
Market Cap/Employee
$31.29M
N/A
Employees
205
N/A
Net Income
-$97.35M
-35.2%
EBITDA
-$94.98M
-34.1%
Quarterly Fundamentals
Total Cash
$866.38M
+252.7%
Total Debt
$238.65M
+1296.4%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$237.27M
+1432.8%
Short Term Debt
$1.38M
-14.2%
Return on Assets
-39.24%
N/A
Return on Invested Capital
-42.84%
N/A
Free Cash Flow
-$87.33M
-30.2%
Operating Cash Flow
-$86.88M
-30.6%